Elazzouzi Amy reported AURA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002042910-26-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 1, 2026

Published

Sep 1, 2026

Ingested by INSIDER

Nov 5, 02:19 UTC

Last re-read

Nov 5, 02:19 UTC

Extracted facts

Filer

Elazzouzi Amy

Role

SVP, Finance & PAO

Transaction

Grant or awardAs filed: “A”

Asset

Aura Biosciences, Inc. — Stock Option (Right to Buy)

Ticker

AURA

Shares

46.5K

Price per share

$0

Execution date (reported)

Sep 1, 2026

Owned after transaction

46.5K shares

Days from execution to publication

0

What this establishes

Elazzouzi Amy filed this Form 4 reporting a grant or award of AURA on Sep 1, 2026. It became public on Sep 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

SVP, Finance & PAO

Elazzouzi Amycik:0002042910

Issuer

Aura Biosciences, Inc.cik:0001501796

Revision history · 0

No field has changed since this record was first ingested.